NYSE · Medical Devices · USD
Medtronic plc. (MDT) Stock Analysis
Medtronic plc. (MDT) is a Medical Devices stock listed on NYSE and quoted in US Dollar.
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
MDT Key Statistics
As of Sep 4, 2026Trading
- Open
- $92.76
- Previous Close
- $93.10
- Day's Range
- 92.31–94.74
- 52-Week Range
- 73.31–106.33
- Volume
- 9.01M
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.57
Valuation
- Market Cap
- $120.46B
- P/E Ratio
- 22.91
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 14.72
- PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
- 1.68
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 3.21
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 4.11
Financials (FY)
- Revenue (FY)
- $36.36B+8.43%
- Net Income (FY)
- $4.80B+2.98%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 13.93%
- Shares Outstanding
- 1.28B
- 1-Year Return
- +4.72%
Dividend and dates
- Dividend
- $2.88+3.09%
- Ex-Dividend Date
- September 25, 2026
- Earnings Date
- November 17, 2026estimated
- Avg Volume
- 8.31M
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
MDT Stock Return by Calendar Year
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | −0.28% |
| 2025 | +24.05% |
| 2024 | +0.28% |
| 2023 | +9.58% |
| 2022 | −22.55% |
| 2021 | −9.79% |
| 2020 | +5.70% |
| 2019 | +27.34% |
| 2018 | +14.60% |
| 2017 | +15.90% |
| 2016 (partial year) | −17.19% |
As of September 4, 2026.
MDT Revenue and Earnings by Fiscal Year
FY ends April| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $36.36B | $4.80B | 13.2% |
| 2024 | $33.54B | $4.66B | 13.9% |
| 2023 | $32.36B | $3.68B | 11.4% |
| 2022 | $31.23B | $3.76B | 12.0% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $36.36B | $23.64B | $6.83B | $4.80B | 13.2% |
| 2024 | $33.54B | $21.91B | $6.54B | $4.66B | 13.9% |
| 2023 | $32.36B | $21.15B | $5.52B | $3.68B | 11.4% |
| 2022 | $31.23B | $20.51B | $5.83B | $3.76B | 12.0% |
Annual figures as reported, in the company's reporting currency. As of April 30, 2026.
MDT Dividend History
Dividends per share, 2025 · 4 payments
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026* | $1.43 | 2 | — |
| 2025 | $2.83 | 4 | +1.4% |
| 2024 | $2.79 | 4 | +1.5% |
| 2023 | $2.75 | 4 | +3.0% |
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026 (partial year) | $1.43 | 2 | — |
| 2025 | $2.83 | 4 | +1.4% |
| 2024 | $2.79 | 4 | +1.5% |
| 2023 | $2.75 | 4 | +3.0% |
| 2022 | $2.67 | 4 | +8.1% |
| 2021 | $2.47 | 4 | +8.3% |
| 2020 | $2.28 | 4 | +7.5% |
| 2019 | $2.12 | 4 | +45.2% |
| 2018 | $1.46 | 3 | −19.3% |
| 2017 | $1.81 | 4 | +110.5% |
| 2016 | $0.86 | 2 | — |
Most recent payment: $0.72 per share, ex-dividend June 26, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.
MDT Valuation vs Medical Devices Median
Median of 151 stocks| Metric | MDT | Medical Devices median | vs median |
|---|---|---|---|
| P/E | 22.91 | 26.80 | 15% below |
| P/S ratio | 3.21 | 2.98 | 8% above |
| Profit margin | 13.93% | −1.69% | 15.6 pts above |
Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.
Recent News
Medtronic (NYSE:MDT) Flashes a High-Quality Breakout Setup
ChartMillMedtronic executives to speak at upcoming investor conferences
Yahoo4 Reasons to Buy Medtronic Stock Like There's No Tomorrow
YahooUBS Maintains Buy on Medtronic, Raises Price Target to $110
BenzingaMedtronic Begins Fiscal 2027 With a Beat-and-Raise, Validating Growth Acceleration, RBC Says
YahooIs Medtronic Stock Underperforming the Dow?
Yahoo
All 20 articles ↓Show fewer ↑
MDT Q1 Earnings Call Focuses on Broad Growth, Raised Guidance
YahooMedtronic raises FY27 outlook after reporting strong Q1 growth
YahooTruist Securities Reiterates Hold on Medtronic, Raises Price Target to $99
BenzingaMedtronic Posts Q1 Beat, 2027 Outlook Raise Validates Growth Inflection
BenzingaWells Fargo Maintains Overweight on Medtronic, Raises Price Target to $104
BenzingaMedtronic invests $700M in Cornerstone Robotics
YahooRBC Capital Reiterates Outperform on Medtronic, Maintains $118 Price Target
BenzingaB of A Securities Maintains Buy on Medtronic, Raises Price Target to $110
BenzingaMedtronic Analysts Raise Their Forecasts After Upbeat Q1 Earnings
BenzingaStifel Maintains Hold on Medtronic, Raises Price Target to $95
BenzingaBaird Maintains Neutral on Medtronic, Raises Price Target to $100
BenzingaMedtronic plc Q1 2027 Earnings Call Summary
YahooHow To Earn $500 A Month From Medtronic Stock Ahead Of Q1 Earnings
YahooTesla, Apple, Nvidia, Medtronic, Alumis, Robinhood, Fervo, and More Stocks That Explain Today’s Market
Yahoo
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.
Related Medical Devices Stocks
Abbott Laboratories
$187.45B
SYKStryker Corporation
$116.27B
BSXBoston Scientific Corporation
$69.27B
EWEdwards Lifesciences Corporation
$51.82B
DXCMDexCom, Inc.
$33.17B
GEHCGE HealthCare Technologies Inc.
$31.10B
Popular Healthcare Stocks
Eli Lilly and Company
$1.02T
JNJJohnson & Johnson
$663.28B
ABBVAbbVie Inc.
$453.19B
MRKMerck & Co., Inc.
$370.89B
UNHUnitedHealth Group Incorporated
$356.47B